(Q36945988)

17 August 2017

title

Pitfalls in the diagnosis of prostatic cancer: retrospective review of 1791 cases with clinical outcome (English)

1 reference

17 August 2017

D M Berney

1

1 reference

17 August 2017

G Fisher

2

1 reference

17 August 2017

M W Kattan

3

1 reference

17 August 2017

R T D Oliver

4

1 reference

17 August 2017

H Møller

5

1 reference

17 August 2017

P Fearn

6

1 reference

17 August 2017

J Eastham

7

1 reference

17 August 2017

P Scardino

8

1 reference

17 August 2017

J Cuzick

9

1 reference

17 August 2017

V E Reuter

10

1 reference

17 August 2017

C S Foster

11

1 reference

17 August 2017

Trans-Atlantic prostate group

12

1 reference

17 August 2017

publication date

1 October 2007

1 reference

17 August 2017

1 reference

17 August 2017

volume

51

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

452-457

1 reference

Does asymptomatic inflammation increase PSA? A histopathological study comparing benign and malignant tissue biopsy specimens

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02819.X

Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02819.X

Effect of peripheral biopsies in maximising early prostate cancer detection in 8-, 10- or 12-core biopsy regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02819.X

Critical evaluation of the current indications for transition zone biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02819.X

Variations in the processing of prostatic needle cores in the UK; what is safe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02819.X

Technical variations in prostatic immunohistochemistry: need for standardisation and stringent quality assurance in PSA and PSAP immunostaining

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02819.X

Long-term outcome among men with conservatively treated localised prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02819.X

The differential diagnosis of prostatic carcinoma. Its distinction from premalignant and pseudocarcinomatous lesions of the prostate gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02819.X

Clinical and cost impact of second-opinion pathology. Review of prostate biopsies prior to radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02819.X

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02819.X

Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02819.X

A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2007.02819.X

10.1111/J.1365-2559.2007.02819.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference